Literature DB >> 2451830

Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes.

T J Elliott1, H N Eisen.   

Abstract

To investigate how T cells recognize allogeneic class I proteins encoded by the major histocompatibility complex (MHC), we examined the human cytotoxic T lymphocytes (CTL) elicited in a mixed lymphocyte reaction against a lymphoblastoid B-cell line (JY) whose MHC-class I proteins are HLA-A2 and -B7. By panning the responding T cells on plates that were coated with purified HLA-A2, an essentially pure population of CD8+ anti-HLA-A2 CTL was isolated in a single step and established as a cell line designated A2p. In addition to lysing HLA-A2+ target cells, the A2p cells lysed HLA-A2- cells, including mouse cells (P815), when purified native HLA-A2 was attached to them, but not when denatured HLA-A2 was attached. Thus, contrary to the general rule that T cells recognize sequential antigenic determinants in denatured protein antigens, the alloreactive CTLs appear to recognize determinants that depend upon the native configuration of HLA-A2; however, the possibility that these T cells recognize a peptide adduct persistently associated with purified, soluble HLA-A2 has not been ruled out.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451830      PMCID: PMC280072          DOI: 10.1073/pnas.85.8.2728

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes: implications for immunotherapy.

Authors:  T J Elliott; M J Glennie; H M McBride; G T Stevenson
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

2.  Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2.

Authors:  P Parham; C Clayberger; S L Zorn; D S Ludwig; G K Schoolnik; A M Krensky
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

3.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

5.  Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.

Authors:  C G Brooks; M Holscher; D Urdal
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

6.  The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.

Authors:  J P Ways; P Parham
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

7.  Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.

Authors:  D M Kranz; S Tonegawa; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation.

Authors:  P Parham; B N Alpert; H T Orr; J L Strominger
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

9.  Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.

Authors:  M G Mage; L L McHugh; T L Rothstein
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

10.  Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor.

Authors:  R D Bigler; D N Posnett; N Chiorazzi
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  8 in total

1.  Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule.

Authors:  T J Elliott; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL).

Authors:  R Hausmann; N Zavazava; J Steinmann; W Müller-Ruchholtz
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the alpha helices and beta sheets of the class I peptide binding site.

Authors:  H D Hunt; T I Munitz; L R Pease
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

5.  Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.

Authors:  G S Ogg; P R Dunbar; V Cerundolo; A J McMichael; N R Lemoine; P Savage
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

6.  Engineered off-the-shelf therapeutic T cells resist host immune rejection.

Authors:  Feiyan Mo; Norihiro Watanabe; Mary K McKenna; M John Hicks; Madhuwanti Srinivasan; Diogo Gomes-Silva; Erden Atilla; Tyler Smith; Pinar Ataca Atilla; Royce Ma; David Quach; Helen E Heslop; Malcolm K Brenner; Maksim Mamonkin
Journal:  Nat Biotechnol       Date:  2020-07-13       Impact factor: 54.908

Review 7.  Strategies for Dodging the Obstacles in CAR T Cell Therapy.

Authors:  Pooria Safarzadeh Kozani; Pouya Safarzadeh Kozani; Fatemeh Rahbarizadeh; Shahryar Khoshtinat Nikkhoi
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

Review 8.  Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward.

Authors:  Pouya Safarzadeh Kozani; Pooria Safarzadeh Kozani; Fatemeh Rahbarizadeh
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.